Skip to main content
Clinical Trials/NL-OMON20428
NL-OMON20428CompletedNot Applicable

Deep brain stimulation (DBS) of the nucleus accumbens in treatment-refractory patients with obsessive-compulsive disorder (OCD).

Implantation equipment is provided by Medtronic Europe, Tolochenaz, Switzerland.No personal funding of research personell.0 sites16 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
16

Study Overview

Brief Summary

/A

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Primary diagnosis: OCD (300.3) according to DSM-IV criteria using the MINI Plus-interview as diagnostic instrument;
  • 2. Illness duration > 5 years;

Exclusion Criteria

  • Any of the following: unstable physical condition, Parkinson's disease, dementia, epilepsy, schizophrenia or history of psychosis, alcohol or substance abuse during last 6 months, current tic disorder, antisocial personality disorder, body dismorphic disorder, pregnancy, use of psychiatric medication other than: stable use of one SSRI or clomipramine, one benzodiazepine, one atypical antipsychotic.

Investigators

Sponsor
Implantation equipment is provided by Medtronic Europe, Tolochenaz, Switzerland.No personal funding of research personell.

Similar Trials

Deep brain stimulation (DBS) of the... | Clinical Trial